坦洛新缓释片与托特罗定治疗前列腺增生伴膀胱过度活动症效果比较观察(1)
【摘 要】 目的:对比坦洛新缓释片、托特罗定治疗前列腺增生伴膀胱过度活动症的临床疗效。方法:选取53例前列腺增生伴膀胱过度活动症患者,双盲法分组,A组采用坦洛新缓释片,B组采用托特罗定,对比2组效果。结果:A组与B组治疗后,USPSS评分、IPSS评分均有改善,但数据对比无明显差异(P>0.05);A组与B组用药不良反应发生率(15.38%VS18.52%)无明显差异(P>0.05)。结论:临床试验证实,坦洛新缓释片、托特罗定治疗前列腺增生伴膀胱过度活动症,疗效相当。【关键词】 前列腺增生;膀胱过度活动症;坦洛新缓释片;托特罗定
【中图分类号】
R181.3+2 【文献标志码】
A 【文章编号】1005-0019(2019)07-070-01
Comparison of Tamsulosin Sustained Release Tablets and Tolterodine in the Treatment of Prostatic Hyperplasia with Overactive Bladder
Abstract Objective:Purpose To compare the clinical efficacy of Tamsulosin sustained-release tablets and Tolterodine in the treatment of benign prostatic hyperplasia with overactive bladder.Method Fifty-three patients with benign prostatic hyperplasia and overactive bladder were divided into two groups by double-blind method. Tamsulosin sustained-release tablets were used in group A and tolterodine in group B.Results After treatment ......
您现在查看是摘要页,全文长 3358 字符。